Borderpolar: Diagnosis and Treatment of Patients with Bipolar Disorder and Borderline Personality Disorder

Borderpolar: Diagnosis and Treatment of Patients with Bipolar Disorder and Borderline Personality Disorder

On-Demand Webcast
FACULTY

Mark Zimmerman, MD
Director of Outpatient Psychiatry
Director of the Partial Hospital Program
Rhode Island Hospital
Professor of Psychiatry
Brown Medical School
Providence, Rhode Island

For full faculty bios, please call 609-371-1137.

TO DOWNLOAD SLIDES CLICK HERE.

PROVIDER STATEMENT

Provided by North American Center for Continuing Medical Education, LLC, an HMP Company.

For questions regarding this educational activity, please call 609-371-1137 or email info@naccme.com.

 

INTENDED LEARNERS

This activity is intended for psychiatrists, primary care physicians, psychologists, physician assistants, psychiatric nurses, and other healthcare professionals who seek to improve the care of patients with mental health disorders.

LEARNING OBJECTIVES

After completing this activity, participants should be able to:

  • Review the level of comorbidity between bipolar disorder and borderline personality disorder (BPD)
  • Identify the differences between patients with borderpolar and BPD, and between patients with borderpolar and bipolar disorder
  • Assess the empirical literature on the treatment of patients with both bipolar disorder and BPD
ACTIVITY OVERVIEW

To be eligible for documentation of credit, participants must participate in the full activity, complete the 10-question post-test with a score of 70% or better, and complete the evaluation form. Participants who successfully complete the post-test and evaluation form online may immediately print their documentation of credit.

Participants who have successfully completed the live version of this activity are not eligible to receive credit for this enduring material.

Release Date: 12/1/2019
Expiration Date: 12/31/2020
Estimated time to complete: 1.25 hours

For questions regarding this educational activity, please call 609-371-1137.

ACCREDITATION INFORMATION

In support of improving patient care, North American Center for Continuing Medical Education, LLC (NACCME) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

CME

NACCME designates this enduring material for a maximum of 1.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

PHYSICIAN ASSISTANTS

NACCME has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with the AAPA CME Criteria. This activity is designated for 1.25 AAPA Category 1 credit(s). PAs should only claim credit commensurate with the extent of their participation in the activity.

CNE

This continuing nursing education activity awards 1.25 contact hours.

Provider approved by the California Board of Registered Nursing, Provider #13255 for 1.25 contact hours.

NURSING PHARMACOLOGY HOURS

This continuing nursing educational activity awards up to 0.25 pharmacology hours.

CE INFORMATION: Psychologists

As a jointly accredited organization, North American Center for Continuing Medical Education, LLC (NACCME) is approved by the American Psychological Association to sponsor continuing education for psychologists. NACCME maintains responsibility for this program and its content. Variable credit for partial attendance may not be awarded. Full attendance is required for all CE activities.

Instructional Level: Advanced

CE Information: Social Workers (ASWB ACE)

NACCME is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved under this program. State and provincial regulatory boards have the final authority to determine whether an individual course may be accepted for continuing education credit. NACCME maintains responsibility for this course. Social workers completing this course receive 1.25 Intermediate continuing education credits.

PLANNING COMMITTEE

The planning committee comprises James Cannon, PhD, MS, PA-C, CAQ-Psy, DFAAPA; Julie Carbray, PhD, PMHNPBC, PMHCNS-BC, APRN; Steven Chan, MD, MBA; Jon W. Draud, MS, MD; Rakesh Jain, MD, MPH; Saundra Jain, MA, PSyD, LPC; Catherine Judd, MS, PA-C, CAQ-Psy, DFAAPA; Edward Kaftarian, MD; Vladimir Maletic, MD, MS; Andrew Penn, RN, MS, NP, APRN-BC; Arwen Podesta, MD, ABPN, FASAM, ABIHM; Charles L. Raison, MD; Douglas L. Noorsdy, MD; William C. Torrey, MD; and Meaghan Benci, Raquel Gaerlan, Jennifer Ilcyn, Mary Johnson, Horacio Rodriguez, Randy Robbin, Kelly Sweeney, and Chris Bolwell.

Independent Clinical Reviewers: 

Douglas L. Noordsy, MD
Clinical Professor of Psychiatry & Behavioral Sciences, Stanford University School of Medicine; Director of Sports Psychiatry, Department of Psychiatry & Behavioral Sciences, Stanford University, Stanford, California

William C. Torrey, MD
Professor and Vice Chair for Clinical Services, Dartmouth’s Geisel School of Medicine, Dartmouth-Hitchcock, Lebanon, New Hampshire

Nurse Planner: 

Andrew Penn, RN, MS, NP, CNS, APRN-BC
Psychiatric Nurse Practitioner, Kaiser Permanente, Redwood City, CA; Assistant Clinical Professor, University of California, San Francisco, CA

FINANCIAL DISCLOSURE AND CONFLICTS OF INTEREST

According to the disclosure policy of NACCME, faculty, editors, managers, and other individuals who are in a position to control content are required to disclose any relevant financial relationships with relevant commercial companies related to this activity. All relevant conflicts of interest that are identified are reviewed for potential conflicts of interest. If a conflict is identified, it is the responsibility of NACCME to initiate a mechanism to resolve the conflict(s). The existence of these interests or relationships is not viewed as implying bias or decreasing the value of the presentation.

All educational materials are reviewed for fair balance, scientific objectivity of studies reported, and levels of evidence.

The faculty reported the following:

Dr. Carbray: Advisory Board: Alkermes.

Dr. Chan: Consultant: Guidewell Innovation; Clinical Psychiatrist: HealthLinkNow, Traditions Behavioral Health.

Dr. Draud: Speakers’ Bureau: Takeda and Lundbeck.

Dr. R. Jain: Advisory Board: Addrenex, Alkermes, Avanir, Forum, Janssen, Lilly, Lundbeck, Merck, Neos Therapeutics, Neurocrine Biosciences, Otsuka, Pamlab, Pfizer, Shionogi, Shire, Sunovion, Supernus, Takeda, Teva; Consultant: Addrenex, Allergan, Avanir, Janssen, Lilly, Lundbeck, Merck, Neos Therapeutics, Neurocrine Biosciences, Otsuka, Pamlab, Pfizer, Shionogi, Shire, Sunovion, Supernus, Takeda, Teva; Consultant (spouse): Lilly, Otsuka, Pfizer, Sunovion; Grant/Research Support: Allergan, AstraZeneca, Lilly, Lundbeck, Otsuka, Pfizer, Shire, Takeda; Speakers Bureau: Addrenex, Alkermes, Allergan, Lilly, Lundbeck, Merck, Otsuka, Pamlab, Pfizer, Rhodes, Shionogi, Shire, Sunovion, Takeda, Tris Pharmaceuticals.

Dr. S. Jain: Advisory Board (spouse): Addrenex, Alkermes, Avanir, Forum, Janssen, Lilly, Lundbeck, Merck, Neos Therapeutics, Neurocrine Biosciences, Otsuka, Pamlab, Pfizer, Shionogi, Shire, Sunovion, Supernus, Takeda, Teva; Consultant (spouse): Addrenex, Allergan, Avanir, Janssen, Lilly, Lundbeck, Merck, Neos Therapeutics, Neurocrine Biosciences, Otsuka, Pamlab, Pfizer, Shionogi, Shire, Sunovion, Supernus, Takeda, Teva; Consultant: Lilly, Otsuka, Pfizer, Sunovion; Grant/Research Support (spouse): Allergan, AstraZeneca, Lilly, Lundbeck, Otsuka, Pfizer, Shire, Takeda; Speakers Bureau (spouse): Addrenex, Alkermes, Allergan, Lilly, Lundbeck, Merck, Otsuka, Pamlab, Pfizer, Rhodes, Shionogi, Shire, Sunovion, Takeda, Tris Pharmaceuticals.

Dr. Kaftarian: Consultant: Orbit Health Telepsychiatry; Major Stock Shareholder: Orbit Health Telepsychiatry.

Dr. Maletic: Consultant: Alkermes, Inc., Allergan, Eisai-Purdue, Janssen, Lundbeck A/S, Otsuka America Pharmaceu

NACCME planners and staff include Meaghan Benci, Chris Bolwell, Raquel Gaerlan, Jennifer Ilcyn, Horacio Rodriguez, Randy Robbin, and Kelly Sweeney

Chris Bolwell is a shareholder of GlaxoSmithKline. GlaxoSmithKline is not supporting this activity, nor does any content relate to their product/service

Faculty
The faculty has reported the following:

Mark Zimmerman, MD has no financial relationships to disclose relating to the subject matter of this presentation.

UNAPPROVED AND INVESTIGATIONAL USES OF DRUGS AND DEVICES

This activity may contain information about experimental and other uses of drugs or devices that are not currently approved by the Food and Drug Administration (FDA) of the United States or European Medicines Agency (EMA). Participants are encouraged to consult the EMA-approved or FDA-approved product labeling for any drug or device mentioned in this activity before use. The opinions expressed in this document are the opinions of the presenters and do not necessarily reflect the opinions of Imedex, LLC and/or NACCME, LLC.

HARDWARE/SOFTWARE REQUIREMENTS

The evaluation is accessible after the activity via a PC (Windows 7 or newer) or Mac (Mac OS 10.6 or later) computer with current versions of the following browsers: Internet Explorer, Mozilla Firefox, Google Chrome, or Safari. A PDF reader is required for print publications. Please direct technical questions to webmaster@naccme.com.

ADA STATEMENT

North American Center for Continuing Medical Education (NACCME) complies with the legal requirements of the Americans with Disabilities Act and the rules and regulations thereof. If any participant in this educational activity is in need of accommodations, please call 609-371-1137

PRIVACY POLICY

NACCME protects the privacy of personal and other information regarding participants, educational partners, and joint providers. NACCME and our joint providers will not release personally identifiable information to a third party without the individual’s consent, except such information as is required for reporting purposes to the appropriate accrediting agency. NACCME maintains physical, electronic, and procedural safeguards that comply with federal regulations to guard your nonpublic personal information.

Copyright © 2019 by North American Center for Continuing Medical Education, LLC. All rights reserved. No part of this accredited continuing education activity may be reproduced or transmitted in any form or by any means, electronic or mechanical, without first obtaining permission from North American Center for Continuing Medical Education.